Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-022873
Filing Date
2019-04-22
Accepted
2019-04-22 16:17:50
Documents
5
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2612_3defa14a.htm DEFA14A 32560
2 GRAPHIC g26123bci001.gif GRAPHIC 49427
3 GRAPHIC g26123bci002.gif GRAPHIC 101352
4 GRAPHIC g26123bci003.gif GRAPHIC 21464
5 GRAPHIC g26123bci004.gif GRAPHIC 4312
  Complete submission text file 0001104659-19-022873.txt   277061
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 19759600
SIC: 2834 Pharmaceutical Preparations